Division of Transplant Surgery, Department of Surgery, Weill Cornell Medical College, New York, NY 10065, USA.
Clin Transplant. 2012 May-Jun;26(3):E213-22. doi: 10.1111/j.1399-0012.2012.01606.x. Epub 2012 Mar 12.
Kidney paired donation (KPD) is a safe and effective means of transplantation for transplant candidates with willing but incompatible donors. We report our single-center experience with KPD through participation in the National Kidney Registry. Patient demographics, transplant rates, and clinical outcomes including delayed graft function (DGF), rejection, and survival were analyzed. We also review strategies employed by our center to maximize living donor transplantation through KPD. We entered 44 incompatible donor/recipient pairs into KPD from 9/2007 to 1/2011, enabling 50 transplants. Incompatibility was attributable to blood type (54.4%) and donor-specific sensitization (43.2%). Thirty-six candidates (81.8%) were transplanted after 157 d (median), enabling pre-emptive transplantation in eight patients. Fourteen candidates on the deceased donor waiting list also received transplants. More than 50% of kidneys were received from other transplant centers. DGF occurred in 6%; one-yr rejection rate was 9.1%. One-yr patient and graft survival was 98.0% and 94.8%. KPD involving participation of multiple transplant centers can provide opportunities for transplantation, with potential to expand the donor pool, minimize waiting times, and enable pre-emptive transplantation. Our experience demonstrates promising short-term outcomes; however, longer follow-up is needed to assess the impact of KPD on the shortage of organs available for transplantation.
肾对配对捐赠(KPD)是一种安全有效的移植手段,适用于有意愿但不相容供体的移植候选人。我们通过参与国家肾脏登记处,报告了我们在单中心进行 KPD 的经验。分析了患者人口统计学、移植率以及包括延迟移植物功能(DGF)、排斥和存活在内的临床结果。我们还回顾了我们中心通过 KPD 最大化活体供体移植所采用的策略。我们从 2007 年 9 月至 2011 年 1 月通过 KPD 将 44 对不相容供体/受体配对输入,共进行了 50 次移植。不相容性归因于血型(54.4%)和供体特异性致敏(43.2%)。36 名候选人(81.8%)在 157 天后(中位数)进行了移植,使 8 名患者能够进行抢先移植。14 名在死亡供体等待名单上的候选人也接受了移植。超过 50%的肾脏来自其他移植中心。DGF 发生率为 6%;1 年排斥率为 9.1%。1 年患者和移植物存活率分别为 98.0%和 94.8%。涉及多个移植中心参与的 KPD 可以提供移植机会,有潜力扩大供体库,缩短等待时间,并实现抢先移植。我们的经验表明,短期结果很有希望;然而,需要更长的随访时间来评估 KPD 对可用器官短缺的影响。